Literature DB >> 24560759

Differences in delineation guidelines for head and neck cancer result in inconsistent reported dose and corresponding NTCP.

Charlotte L Brouwer1, Roel J H M Steenbakkers2, Elske Gort2, Marije E Kamphuis2, Hans Paul van der Laan2, Aart A Van't Veld2, Nanna M Sijtsema2, Johannes A Langendijk2.   

Abstract

PURPOSE: To test the hypothesis that delineation of swallowing organs at risk (SWOARs) based on different guidelines results in differences in dose-volume parameters and subsequent normal tissue complication probability (NTCP) values for dysphagia-related endpoints.
MATERIALS AND METHODS: Nine different SWOARs were delineated according to five different delineation guidelines in 29 patients. Reference delineation was performed according to the guidelines and NTCP-models of Christianen et al. Concordance Index (CI), dosimetric consequences, as well as differences in the subsequent NTCPs were calculated.
RESULTS: The median CI of the different delineation guidelines with the reference guidelines was 0.54 for the pharyngeal constrictor muscles, 0.56 for the laryngeal structures and 0.07 for the cricopharyngeal muscle and esophageal inlet muscle. The average difference in mean dose to the SWOARs between the guidelines with the largest difference (maxΔD) was 3.5±3.2Gy. A mean ΔNTCP of 2.3±2.7% was found. For two patients, ΔNTCP exceeded 10%.
CONCLUSIONS: The majority of the patients showed little differences in NTCPs between the different delineation guidelines. However, large NTCP differences >10% were found in 7% of the patients. For correct use of NTCP models in individual patients, uniform delineation guidelines are of great importance.
Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Delineation guidelines; Head and neck; Interobserver variability; NTCP

Mesh:

Year:  2014        PMID: 24560759     DOI: 10.1016/j.radonc.2014.01.019

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Optimising Radiation Therapy Dose to the Swallowing Organs at Risk: An In Silico Study of feasibility for Patients with Oropharyngeal Tumours.

Authors:  Molly K Barnhart; Bena Cartmill; Elizabeth C Ward; Elizabeth Brown; Jonathon Sim; George Saade; Sandra Rayner; Rachelle A Robinson; Virginia A Simms; Robert I Smee
Journal:  Dysphagia       Date:  2019-02-11       Impact factor: 3.438

2.  Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.

Authors: 
Journal:  Radiother Oncol       Date:  2016-02-17       Impact factor: 6.280

Review 3.  Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques.

Authors:  Sonja Stieb; Kendall Kiser; Lisanne van Dijk; Nadia Roxanne Livingstone; Hesham Elhalawani; Baher Elgohari; Brigid McDonald; Juan Ventura; Abdallah Sherif Radwan Mohamed; Clifton David Fuller
Journal:  Hematol Oncol Clin North Am       Date:  2019-10-31       Impact factor: 3.722

4.  Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.

Authors:  Jay A Messer; Abdallah S R Mohamed; Katherine A Hutcheson; Yao Ding; Jan S Lewin; Jihong Wang; Stephen Y Lai; Steven J Frank; Adam S Garden; Vlad Sandulache; Hillary Eichelberger; Chloe C French; Rivka R Colen; Jack Phan; Jayashree Kalpathy-Cramer; John D Hazle; David I Rosenthal; G Brandon Gunn; Clifton D Fuller
Journal:  Radiother Oncol       Date:  2016-01-28       Impact factor: 6.280

5.  Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans.

Authors:  Christian Rønn Hansen; Anders Bertelsen; Irene Hazell; Ruta Zukauskaite; Niels Gyldenkerne; Jørgen Johansen; Jesper G Eriksen; Carsten Brink
Journal:  Clin Transl Radiat Oncol       Date:  2016-09-19

Review 6.  Repetitive MRI of organs at risk in head and neck cancer patients undergoing radiotherapy.

Authors:  Sonja Stieb; Baher Elgohari; Clifton David Fuller
Journal:  Clin Transl Radiat Oncol       Date:  2019-04-26

7.  Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk.

Authors:  Jamie A Dean; Liam C Welsh; Dualta McQuaid; Kee H Wong; Aleksandar Aleksic; Emma Dunne; Mohammad R Islam; Anushka Patel; Priyanka Patel; Imran Petkar; Iain Phillips; Jackie Sham; Kate L Newbold; Shreerang A Bhide; Kevin J Harrington; Sarah L Gulliford; Christopher M Nutting
Journal:  Radiother Oncol       Date:  2016-03-09       Impact factor: 6.280

8.  Metal artefact reduction for accurate tumour delineation in radiotherapy.

Authors:  David Gergely Kovacs; Laura A Rechner; Ane L Appelt; Anne K Berthelsen; Junia C Costa; Jeppe Friborg; Gitte F Persson; Jens Peter Bangsgaard; Lena Specht; Marianne C Aznar
Journal:  Radiother Oncol       Date:  2017-10-16       Impact factor: 6.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.